The Burrill Report


The Burrill Report (February 13, 2012): Can the FDA Get California's Biotech Sector Growing Again? (.MP3,14.85 Mb)

After two decades of steady job growth, employment in California's biomedical industry stalled while the state has struggled to recover from the deep global recession, according to the 2012 California Biomedical Industry Report from the California Healthcare Institute, BayBio, and PwC. California is the source of more than a quarter of the nation's biomedical pipeline and remains a world leader of new innovation in the life sciences, but California's biomedical companies are expanding their out-of-state and foreign operations. We spoke to David Gollaher, CEO of the California Healthcare Institute, about the state of California’s biomedical industry, how companies are coping with the growing risk aversion of investors, and how the regulatory environment in the United States has both companies and investors turning away.

February 10, 2012
http://www.burrillreport.com/article-can_the_fda_get_californias_biotech_sector_growing_again.html